The pharmaceutical industry faces a constant pressure to provide innovative therapies to patients in a timely and cost-effective manner. Contract Development and Manufacturing Organizations (CDMOs) have emerged as key players in optimizing drug development by offering comprehensive solutions for active pharmaceutical ingredients (APIs) and intermed